| Page 158 | Kisaco Research
 

Elio Van Puyvelde

CIO
Nscale

Elio has over 15 years of entrepreneurial experience in HPC and AI industries; Co-Founder of ElioVP, a manufacturer, designer, and operator of premium HPC hardware and software systems.

Elio Van Puyvelde

CIO
Nscale

Elio Van Puyvelde

CIO
Nscale

Elio has over 15 years of entrepreneurial experience in HPC and AI industries; Co-Founder of ElioVP, a manufacturer, designer, and operator of premium HPC hardware and software systems.

 
The UPC Litigation Forum
20 Jan 2025
Amsterdam, Beurs Van Berlage Centre
  
 

Rebecca Sternberg

CEO
Aquafit Intimate

Rebecca Sternberg

CEO
Aquafit Intimate

Rebecca Sternberg

CEO
Aquafit Intimate
 

Paul Scott

CEO
IBEX Innovations

Paul Scott

CEO
IBEX Innovations

Paul Scott

CEO
IBEX Innovations
 

Mahnur Khan

Doctor
NHS

Mahnur Khan

Doctor
NHS

Mahnur Khan

Doctor
NHS
 

Lotus QI

Head Of MedTech
Capital Enterprise

Lotus QI

Head Of MedTech
Capital Enterprise

Lotus QI

Head Of MedTech
Capital Enterprise
 

Lauren Redfern

Executive Director
Hormonally

Lauren Redfern

Executive Director
Hormonally

Lauren Redfern

Executive Director
Hormonally
 

Helen Grimshaw

Co-Founder
Peli Health

Helen Grimshaw

Co-Founder
Peli Health

Helen Grimshaw

Co-Founder
Peli Health
 

Clarice Pinto

Co-Founder
Pausetiv

Clarice Pinto

Co-Founder
Pausetiv

Clarice Pinto

Co-Founder
Pausetiv
 

Eric Ginsburg

Applied Technology Manager - North America, Active Ingredients
Evonik

Eric Ginsburg received his Ph.D. in Medicinal Chemistry from Virginia Commonwealth University in 2020. His graduate work was focused on determining the mechanism of action of platinum-based therapeutics. Upon graduation he started with Evonik as a process chemistry working in their Hopewell Virginia plant. During his time at the plant, Eric supported production by developing methods to help increase robustness of products, while minimizing reactor downtime.

Eric Ginsburg

Applied Technology Manager - North America, Active Ingredients
Evonik

Eric Ginsburg

Applied Technology Manager - North America, Active Ingredients
Evonik

Eric Ginsburg received his Ph.D. in Medicinal Chemistry from Virginia Commonwealth University in 2020. His graduate work was focused on determining the mechanism of action of platinum-based therapeutics. Upon graduation he started with Evonik as a process chemistry working in their Hopewell Virginia plant. During his time at the plant, Eric supported production by developing methods to help increase robustness of products, while minimizing reactor downtime. In December of 2021, Eric joined the Applied Innovation team, where his role is centered around the research and development of Active Ingredients.